HRP20120225T1 - Novi heterociklični spojevi kao mglu5 antagonisti - Google Patents
Novi heterociklični spojevi kao mglu5 antagonisti Download PDFInfo
- Publication number
- HRP20120225T1 HRP20120225T1 HR20120225T HRP20120225T HRP20120225T1 HR P20120225 T1 HRP20120225 T1 HR P20120225T1 HR 20120225 T HR20120225 T HR 20120225T HR P20120225 T HRP20120225 T HR P20120225T HR P20120225 T1 HRP20120225 T1 HR P20120225T1
- Authority
- HR
- Croatia
- Prior art keywords
- pyridyl
- piperidine
- prop
- ynylidene
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95367707P | 2007-08-02 | 2007-08-02 | |
| US4517508P | 2008-04-15 | 2008-04-15 | |
| PCT/EP2008/006351 WO2009015897A1 (en) | 2007-08-02 | 2008-08-01 | Novel heterocyclic compounds as mglu5 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120225T1 true HRP20120225T1 (hr) | 2012-04-30 |
Family
ID=39885225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20120225T HRP20120225T1 (hr) | 2007-08-02 | 2008-08-01 | Novi heterociklični spojevi kao mglu5 antagonisti |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8518916B2 (https=) |
| EP (1) | EP2178858B1 (https=) |
| JP (1) | JP5412430B2 (https=) |
| KR (1) | KR20100052507A (https=) |
| CN (1) | CN101821256A (https=) |
| AT (1) | ATE539075T1 (https=) |
| AU (1) | AU2008282032B2 (https=) |
| BR (1) | BRPI0814182A2 (https=) |
| CA (1) | CA2694359A1 (https=) |
| CY (1) | CY1112500T1 (https=) |
| DK (1) | DK2178858T3 (https=) |
| EA (1) | EA018328B1 (https=) |
| ES (1) | ES2380165T3 (https=) |
| HR (1) | HRP20120225T1 (https=) |
| IL (1) | IL203659A (https=) |
| NZ (1) | NZ582934A (https=) |
| PL (1) | PL2178858T3 (https=) |
| PT (1) | PT2178858E (https=) |
| RS (1) | RS52167B (https=) |
| SI (1) | SI2178858T1 (https=) |
| WO (1) | WO2009015897A1 (https=) |
| ZA (1) | ZA201001467B (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8937148B2 (en) | 2012-09-07 | 2015-01-20 | Empire Technology Development LLP | Regioregular copolymers and methods for making same |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010089119A1 (en) * | 2009-02-04 | 2010-08-12 | Recordati Ireland Limited | Heterocyclic derivatives as m-glu5 antagonists |
| US20120028931A1 (en) * | 2009-09-14 | 2012-02-02 | Recordati Ireland Limited | Heterocyclic m-glu5 antagonists |
| WO2012085166A1 (en) * | 2010-12-22 | 2012-06-28 | Merz Pharma Gmbh & Co. Kgaa | Metabotropic glutamate receptor modulators |
| AR084515A1 (es) * | 2010-12-22 | 2013-05-22 | Merz Pharma Gmbh & Co Kgaa | Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras |
| CN104011016B (zh) * | 2011-12-27 | 2016-08-17 | 帝斯曼知识产权资产管理有限公司 | 维生素a中间体的催化合成 |
| CN102827056B (zh) * | 2012-09-03 | 2014-07-23 | 华东理工大学 | N-芳基取代吡咯烷酮衍生物及其用途 |
| AU2014211727B2 (en) * | 2013-02-04 | 2018-07-26 | Prexton Therapeutics Sa | Positive allosteric modulators of mGluR3 |
| CA3066193A1 (en) * | 2017-06-29 | 2019-01-03 | Recordati Industria Chimica E Farmaceutica Spa | Heterocyclylmethylidene derivatives and their use as modulators of mglur5 receptors |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE24826E (en) * | 1956-08-30 | 1960-05-17 | N-alkylpiperidyl alkynylamines | |
| JPS5995249A (ja) * | 1982-11-24 | 1984-06-01 | Ono Pharmaceut Co Ltd | ロイコトリエンｂ４類似化合物、その製造方法及びそれらを有効成分として含有する治療剤 |
| EP0537993A1 (en) * | 1991-10-17 | 1993-04-21 | Eli Lilly And Company | Nicotinic activity of a series of arecolones and isoarecolones |
| US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
| AP2005003199A0 (en) * | 1999-04-01 | 2005-03-31 | Pfizer Prod Inc | Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| US6265434B1 (en) * | 1999-04-06 | 2001-07-24 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
| TW593241B (en) | 1999-04-20 | 2004-06-21 | Hoffmann La Roche | Carbamic acid derivatives |
| ITMI991452A1 (it) * | 1999-07-01 | 2001-01-01 | Mediolanum Farmaceutici Srl | Antagonisti selettivi per i recettori m2 con struttura 5h-dibenzo b,fazepinica |
| US6387909B1 (en) * | 1999-07-30 | 2002-05-14 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyranecarboxamide derivatives |
| US6306861B1 (en) * | 1999-07-30 | 2001-10-23 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyrancecarboxamide derivatives |
| US6548522B1 (en) | 1999-10-12 | 2003-04-15 | Hoffmann-La Roche Inc. | Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives |
| US6403594B1 (en) * | 1999-10-18 | 2002-06-11 | Recordati, S.A. Chemical And Pharmaceutical Company | Benzopyran derivatives |
| US6365591B1 (en) * | 1999-10-18 | 2002-04-02 | Recordati, S.A., Chemical And Pharmacueticals Company | Isoxazolecarboxamide derivatives |
| EP1230225A2 (en) | 1999-11-01 | 2002-08-14 | Eli Lilly And Company | Pharmaceutically active 4-substituted pyrimidine derivatives |
| ATE273695T1 (de) | 2000-06-28 | 2004-09-15 | Smithkline Beecham Plc | Nassvermahlung |
| US6369222B1 (en) * | 2000-07-18 | 2002-04-09 | Hoffmann-La Roche Inc. | mGluR antagonists and a method for their synthesis |
| WO2003093236A1 (en) * | 2002-05-02 | 2003-11-13 | Euro-Celtique, S.A. | 1-(pyrid-2-yl)-piperazine compounds as metabotropic glutamate receptor inhibitor |
| US7348337B2 (en) * | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| DK1539739T3 (da) * | 2002-08-16 | 2011-03-07 | Janssen Pharmaceutica Nv | Piperidinylforbindelser, der selektivt binder integriner |
| WO2004041777A2 (en) | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Heteroarylpiperidine modulators of chemokine receptor activity |
| US7572922B2 (en) * | 2003-01-27 | 2009-08-11 | Merck & Co., Inc. | Substituted pyrazoles, compositions containing such compounds and methods of use |
| ITMI20030151A1 (it) * | 2003-01-30 | 2004-07-31 | Recordati Ind Chimica E Farma Ceutica S P A | Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore. |
| US7338954B2 (en) * | 2003-09-17 | 2008-03-04 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| FR2866884B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique |
| WO2005097760A1 (en) | 2004-03-26 | 2005-10-20 | Rigel Pharmaceuticals, Inc. | Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| CA2563123A1 (en) * | 2004-04-02 | 2005-10-20 | Adenosine Therapeutics, Llc | Selective antagonists of a2a adenosine receptors |
| GB0503646D0 (en) * | 2005-02-22 | 2005-03-30 | Novartis Ag | Organic compounds |
| AU2006228957A1 (en) * | 2005-04-01 | 2006-10-05 | Methylgene Inc. | Inhibitors of histone deacetylase |
| GB0514296D0 (en) * | 2005-07-12 | 2005-08-17 | Novartis Ag | Organic compounds |
| US8334290B2 (en) * | 2005-10-31 | 2012-12-18 | Merck Sharp & Dohme Corp. | CETP inhibitors |
| KR101495611B1 (ko) * | 2006-04-07 | 2015-02-25 | 메틸진 인코포레이티드 | 히스톤 데아세틸라아제의 억제제 |
| US7985754B2 (en) | 2006-07-17 | 2011-07-26 | Trovis Pharmaceuticals, Llc | Selective antagonists of A2A adenosine receptors |
-
2008
- 2008-08-01 PT PT08785292T patent/PT2178858E/pt unknown
- 2008-08-01 ES ES08785292T patent/ES2380165T3/es active Active
- 2008-08-01 KR KR1020107004641A patent/KR20100052507A/ko not_active Ceased
- 2008-08-01 EA EA201000283A patent/EA018328B1/ru not_active IP Right Cessation
- 2008-08-01 SI SI200830533T patent/SI2178858T1/sl unknown
- 2008-08-01 DK DK08785292.7T patent/DK2178858T3/da active
- 2008-08-01 JP JP2010518567A patent/JP5412430B2/ja not_active Expired - Fee Related
- 2008-08-01 WO PCT/EP2008/006351 patent/WO2009015897A1/en not_active Ceased
- 2008-08-01 AU AU2008282032A patent/AU2008282032B2/en not_active Expired - Fee Related
- 2008-08-01 NZ NZ582934A patent/NZ582934A/en not_active IP Right Cessation
- 2008-08-01 RS RS20120110A patent/RS52167B/sr unknown
- 2008-08-01 AT AT08785292T patent/ATE539075T1/de active
- 2008-08-01 EP EP08785292A patent/EP2178858B1/en active Active
- 2008-08-01 HR HR20120225T patent/HRP20120225T1/hr unknown
- 2008-08-01 BR BRPI0814182-7A2A patent/BRPI0814182A2/pt not_active IP Right Cessation
- 2008-08-01 CA CA2694359A patent/CA2694359A1/en not_active Abandoned
- 2008-08-01 PL PL08785292T patent/PL2178858T3/pl unknown
- 2008-08-01 CN CN200880101389A patent/CN101821256A/zh active Pending
- 2008-08-04 US US12/185,639 patent/US8518916B2/en not_active Expired - Fee Related
-
2010
- 2010-02-02 IL IL203659A patent/IL203659A/en not_active IP Right Cessation
- 2010-03-01 ZA ZA2010/01467A patent/ZA201001467B/en unknown
-
2012
- 2012-03-21 CY CY20121100296T patent/CY1112500T1/el unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8937148B2 (en) | 2012-09-07 | 2015-01-20 | Empire Technology Development LLP | Regioregular copolymers and methods for making same |
| US9181287B2 (en) | 2012-09-07 | 2015-11-10 | Empire Technology Development Llc | Regioregular copolymers and methods for making same |
Also Published As
| Publication number | Publication date |
|---|---|
| DK2178858T3 (da) | 2012-03-19 |
| EP2178858A1 (en) | 2010-04-28 |
| JP2010535165A (ja) | 2010-11-18 |
| CY1112500T1 (el) | 2015-12-09 |
| WO2009015897A1 (en) | 2009-02-05 |
| NZ582934A (en) | 2011-10-28 |
| BRPI0814182A2 (pt) | 2015-01-27 |
| EA201000283A1 (ru) | 2010-06-30 |
| ES2380165T3 (es) | 2012-05-09 |
| RS52167B (sr) | 2012-08-31 |
| AU2008282032A1 (en) | 2009-02-05 |
| ATE539075T1 (de) | 2012-01-15 |
| CA2694359A1 (en) | 2009-02-05 |
| HK1141788A1 (en) | 2010-11-19 |
| ZA201001467B (en) | 2010-11-24 |
| EA018328B1 (ru) | 2013-07-30 |
| US20090042841A1 (en) | 2009-02-12 |
| CN101821256A (zh) | 2010-09-01 |
| JP5412430B2 (ja) | 2014-02-12 |
| EP2178858B1 (en) | 2011-12-28 |
| KR20100052507A (ko) | 2010-05-19 |
| US8518916B2 (en) | 2013-08-27 |
| SI2178858T1 (sl) | 2012-03-30 |
| IL203659A (en) | 2013-06-27 |
| AU2008282032B2 (en) | 2014-08-07 |
| PT2178858E (pt) | 2012-02-24 |
| PL2178858T3 (pl) | 2012-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20120225T1 (hr) | Novi heterociklični spojevi kao mglu5 antagonisti | |
| JP2010535165A5 (https=) | ||
| JP2006500348A5 (https=) | ||
| US6562811B1 (en) | Pyridine derivatives | |
| AU2001277754B2 (en) | Proline derivatives and use thereof as drugs | |
| AU2004209495A1 (en) | Pyrazole derivative | |
| AU2007304475B2 (en) | Substituted sulfonamide derivatives | |
| CA2771568A1 (en) | Heteroaryl compounds as kinase inhibitors | |
| JP2019523266A5 (https=) | ||
| KR101736424B1 (ko) | 수면 장애 및 약물 중독의 치료에 적합한 스피로 아미노 화합물 | |
| RU2005122932A (ru) | Производные бензазепина для лечения неврологических нарушений | |
| EP3423451A1 (en) | Inhibitors of wdr5 protein-protein binding | |
| CN102197032A (zh) | 杂环pim-激酶抑制剂 | |
| KR20010083055A (ko) | 글리코겐 신타제 키나제 3의 억제제 | |
| RU2005134006A (ru) | Производные 4-(4-{гетероциклилалкокси}фенил0-1-(гетероциклилкарбонил)пиперидина и родственные соединения как антагонисты гистамина н3 для лечения неврологических заболеваний, таких как болезнь альцгеймера | |
| CA2520027A1 (en) | 2,3,6-trisubstituted-4-pyrimidone derivatives | |
| AU2016291158A1 (en) | Substituted 4-azaindoles and their use as glun2b receptor modulators | |
| AU2010291199A1 (en) | Pyrazinylpyridines useful for the treatment of proliferative diseases | |
| RU2009105829A (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb | |
| EP2473499A1 (en) | Bipyridines useful for the treatment of proliferative diseases | |
| JP2017512184A5 (https=) | ||
| JP2008513405A5 (https=) | ||
| KR20200024111A (ko) | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 | |
| CA2522536A1 (en) | Five-membered heterocyclic derivative | |
| TW202028188A (zh) | 新穎胺基-嘧啶酮基-哌啶基衍生物、其製備之方法及包含其之醫藥組合物 |